Edward R. Grauch - Nov 4, 2022 Form 4 Insider Report for BLONDER TONGUE LABORATORIES INC (BDRL)

Role: CEO & President
Signature: /s/ Edward R. Grauch by Eric Skolnik Under Power of Attorney
Stock symbol: BDRL
Transactions as of: Nov 4, 2022
Transactions value $: $10,169
Form type: 4
Date filed: 11/7/2022, 03:20 PM
Previous filing: Oct 24, 2022
Next filing: Nov 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDRL	Common Stock, par value $0.001	Award	$1.04K	+5.77K	+0.56%	$0.18	1.04M	Nov 4, 2022	Direct	F1
transaction	BDRL	Common Stock, par value $0.001	Award	$9.13K	+50.7K	+4.86%	$0.18	1.09M	Nov 4, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date).

Content

Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date).